BNC

• Challenges in the broader cannabis environment with pricing and inflationary pressures, reduced investment in controlled environment agriculture leading to reduced capital expenditures and impact on net bookings and revenue.
• Preemptively implemented cost-cutting initiatives reducing operating expenses by over 60% compared to the year-ago period, with disciplined approach to capital allocation in product development, marketing, and personnel.
• Initiated review of strategic alternatives including sale, merger, etc., with Board retaining Roth Capital Partners as financial advisor.
• Plan to identify additional savings opportunities, continue servicing current contracts, and diversify customer base across cannabis and traditional agricultural sectors.
• Q2 revenue, net bookings, backlog, gross profit, operating expenses, net loss, and cash position discussed by Ian Patel.

• Continue to run lean operation while targeting new contract wins in cannabis and traditional agriculture verticals.
• Well-positioned with robust balance sheet, optimized cost structure, and prudent capital allocation to navigate challenging environment and deliver value to customers and shareholders.

Q2 revenue was $1.1 million compared to $3 million in the year-ago period. Gross profit for Q2 2023 was approximately $79,000 or 7.4% of revenue compared to $300,000 or 10.2% of revenue in the same period last year. Operating expenses in Q2 decreased 62% to approximately $800,000, compared to $2.1 million in the year-ago quarter. Net loss for Q2 2023 improved to approximately $700,000 or negative $0.09 per share compared to a net loss of $1.8 million or negative $0.23 per share in the year-ago quarter. Cash and cash equivalents as of June 30, 2023, were $14.2 million compared to $18.6 million as of December 31, 2022, and the company remained debt-free.

• Volatility in the broader cannabis environment with pricing and inflationary pressures.
• Reduction in investment in and reorganization within the controlled environment agricultural sector leading to reduced capital expenditures and delayed/eliminated construction projects impacting net bookings and revenue.

Q: Are you planning to report updates on the strategic alternatives? And if so, how frequently?

A: We will provide updates on the process as our Board deems appropriate.

Q: On the M&A front, what characteristics are you looking for in a partner or a acquirer?

A: We are casting a wide net to ensure the greatest outcome for shareholders, consistent with our Board’s established guidance. This includes partners both inside and outside the cannabis and CEA Industries.

Q: Has your ability to win new contracts been impacted by the reduction in your sales and marketing investment?

A: As we mentioned in our prepared remarks, we’ve seen a slowdown in contract opportunities and have - as such have reduced our sales and marketing efforts accordingly. We will continue to evaluate new business opportunities, and we will of course continue servicing our customers for current and new projects.

Q: Given the challenges in the indoor agriculture and cannabis sectors, do you plan to pivot to any new -- or any adjacent or new categories?

A: As I mentioned earlier, the Board is casting a wide net for this strategic review process. That includes targeting opportunities in cannabis and agriculture as well as other industries that can drive the greatest shareholder value.